The DOI matches its Crossref record; 98 of the 98 references it cites were found in a registry or an index.
Oncogenic cancer/testis antigens: prime candidates for immunotherapy
Open accessAbstract
// Morten F. Gjerstorff 1 , Mads H. Andersen 2 and Henrik J. Ditzel 1,3 1 Department of Cancer and Inflammation Research, University of Southern Denmark, Odense, Denmark 2 Department of Haematology, Center for Cancer Immune Therapy (CCIT), Copenhagen University Hospital, Herlev, Denmark 3 Department of Oncology, Odense University Hospital, Odense, Denmark Correspondence to: Morten Gjerstorff, email: // Keywords : cancer/testis antigen, oncogenesis, immunotherapy Received : May 19, 2015 Accepted : June 21, 2015 Published : June 30, 2015 Abstract Recent developments have set the stage for immunotherapy as a supplement to conventional cancer treatment. Consequently, a significant effort is required to further improve efficacy and specificity, particularly the identification of optimal therapeutic targets for clinical testing. Cancer/testis antigens are immunogenic, highly cancer-specific, and frequently expressed in various types of cancer, which make them promising candidate targets for cancer immunotherapy, including cancer vaccination and adoptive T-cell transfer with chimeric T-cell receptors. Our current understanding of tumor immunology and immune escape suggests that targeting oncogenic antigens may be beneficial, meaning that identification of cancer/testis antigens with oncogenic properties is of high priority. Recent work from our lab and others provide evidence that many cancer/testis antigens, in fact, have oncogenic functions, including support of growth, survival and metastasis. This novel insight into the function of cancer/testis antigens has the potential to deliver more effective cancer vaccines. Moreover, immune targeting of oncogenic cancer/testis antigens in combination with conventional cytotoxic therapies or novel immunotherapies such as checkpoint blockade or adoptive transfer, represents a highly synergistic approach with the potential to improve patient survival.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative Review
Wanchoo, R., Karam, S., Uppal, N. N., Barta, V. S., Deray, G., Devoe, C., Launay-Vacher, V., Jhaveri, K. D., & on behalf of Cancer and Kidney International Network Workgroup on Immune Checkpoint Inhibitors (2017) · American Journal of Nephrology · doi:10.1159/000455014 · Cited by 15,256
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
Schreiber, R. D., Old, L. J., & Smyth, M. J. (2011) · Science · doi:10.1126/science.1203486 · Cited by 6,474
Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496
Molecular and genetic properties of tumors associated with local immune cytolytic activity
Rooney, M. S., Shukla, S. A., Wu, C. J., Getz, G., & Hacohen, N. (2015) · Cell · doi:10.1016/j.cell.2014.12.033 · Cited by 3,825
A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma
van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., & Boon, T. (1991) · Science · doi:10.1126/science.1840703 · Cited by 3,545
Regulatory networks defining EMT during cancer initiation and progression
Craene, B. D., & Berx, G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3447 · Cited by 2,487
Topalian, S. L., Sznol, M., McDermott, D. F., Kluger, H. M., Carvajal, R. D., Sharfman, W. H., Brahmer, J. R., Lawrence, D. P., Atkins, M. B., Powderly, J. D., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.53.0105 · Cited by 2,222
Keeney, S., Giroux, C. N., & Kleckner, N. (1997) · Cell · doi:10.1016/s0092-8674(00)81876-0 · Cited by 1,809
Robbins, P. F., Morgan, R. A., Feldman, S. A., Yang, J. C., Sherry, R. M., Dudley, M. E., Wunderlich, J. R., Nahvi, A. V., Helman, L. J., Mackall, C. L., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.2537 · Cited by 1,632
Dudley, M. E., Yang, J. C., Sherry, R., Hughes, M. S., Royal, R., Kammula, U., Robbins, P. F., Huang, J., Citrin, D. E., Leitman, S. F., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.5449 · Cited by 1,332
A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening
Chen, Y.-T., Scanlan, M. J., Sahin, U., Türeci, Ö., Gure, A. O., Tsang, S., Williamson, B., Stockert, E., Pfreundschuh, M., & Old, L. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1914 · Cited by 1,247
Linette, G. P., Stadtmauer, E. A., Maus, M. V., Rapoport, A. P., Levine, B. L., Emery, L., Litzky, L., Bagg, A., Carreno, B. M., Cimino, P. J., et al. (2013) · Blood · doi:10.1182/blood-2013-03-490565 · Cited by 1,179
Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy
Morgan, R. A., Chinnasamy, N., Abate-Daga, D., Gros, A., Robbins, P. F., Zheng, Z., Dudley, M. E., Feldman, S. A., Yang, J. C., Sherry, R. M., et al. (2013) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3182829903 · Cited by 1,148
Walter, S., Weinschenk, T., Stenzl, A., Zdrojowy, R., Pluzanska, A., Szczylik, C., Staehler, M., Brugger, W., Dietrich, P.-Y., Mendrzyk, R., et al. (2012) · Nature Medicine · doi:10.1038/nm.2883 · Cited by 788
Cameron, B. J., Gerry, A. B., Dukes, J., Harper, J. V., Kannan, V., Bianchi, F. C., Grand, F., Brewer, J. E., Gupta, M., Plesa, G., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006034 · Cited by 684
The testis in immune privilege
Fijak, M., & Meinhardt, A. (2006) · Immunological Reviews · doi:10.1111/j.1600-065x.2006.00438.x · Cited by 483
MAGE-RING Protein Complexes Comprise a Family of E3 Ubiquitin Ligases
Doyle, J. M., Gao, J., Wang, J., Yang, M., & Potts, P. R. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.08.029 · Cited by 467
CTdatabase: a knowledge-base of high-throughput and curated data on cancer-testis antigens
Almeida, L. G., Sakabe, N. J., deOliveira, A. R., Silva, M. C. C., Mundstein, A. S., Cohen, T., Chen, Y.-T., Chua, R., Gurung, S., Gnjatic, S., et al. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn673 · Cited by 433
Dhodapkar, M. V., Sznol, M., Zhao, B., Wang, D., Carvajal, R. D., Keohan, M. L., Chuang, E., Sanborn, R. E., Lutzky, J., Powderly, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008068 · Cited by 365
Gotter, J., Brors, B., Hergenhahn, M., & Kyewski, B. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031677 · Cited by 359
Goodyear, O., Agathanggelou, A., Novitzky-Basso, I., Siddique, S., McSkeane, T., Ryan, G., Vyas, P., Cavenagh, J., Stankovic, T., Moss, P., et al. (2010) · Blood · doi:10.1182/blood-2009-11-249474 · Cited by 340
Genome-wide analysis of cancer/testis gene expression
Hofmann, O., Caballero, O. L., Stevenson, B. J., Chen, Y.-T., Cohen, T., Chua, R., Maher, C. A., Panji, S., Schaefer, U., Kruger, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810777105 · Cited by 336
Spo11 and the Formation of DNA Double-Strand Breaks in Meiosis
Keeney, S. (2007) · Genome Dynamics and Stability · doi:10.1007/7050_2007_026 · Cited by 330
Yang, B., O'Herrin, S. M., Wu, J., Reagan-Shaw, S., Ma, Y., Bhat, K. M. R., Gravekamp, C., Setaluri, V., Peters, N., Hoffmann, F. M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1478 · Cited by 272
Monte, M., Simonatto, M., Peche, L. Y., Bublik, D. R., Gobessi, S., Pierotti, M. A., Rodolfo, M., & Schneider, C. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510834103 · Cited by 257
Throwing the cancer switch: reciprocal roles of polycomb and trithorax proteins
Mills, A. A. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2931 · Cited by 249
Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage
Barrow, C., Browning, J., MacGregor, D., Davis, I. D., Sturrock, S., Jungbluth, A. A., & Cebon, J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1544 · Cited by 238
Apoptosis and cancer chemotherapy
Makin, G., & Hickman, J. A. (2000) · Cell and Tissue Research · doi:10.1007/s004419900160 · Cited by 226
Jäger, E., Karbach, J., Gnjatic, S., Neumann, A., Bender, A., Valmori, D., Ayyoub, M., Ritter, E., Ritter, G., Jäger, D., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606512103 · Cited by 216
Gnjatic, S., Atanackovic, D., Jäger, E., Matsuo, M., Selvakumar, A., Altorki, N. K., Maki, R. G., Dupont, B., Ritter, G., Chen, Y.-T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1133324100 · Cited by 203
Odunsi, K., Matsuzaki, J., Karbach, J., Neumann, A., Mhawech-Fauceglia, P., Miller, A., Beck, A., Morrison, C. D., Ritter, G., Godoy, H., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117208109 · Cited by 200
Jungbluth, A. A., Ely, S., DiLiberto, M., Niesvizky, R., Williamson, B., Frosina, D., Chen, Y.-T., Bhardwaj, N., Chen-Kiang, S., Old, L. J., et al. (2005) · Blood · doi:10.1182/blood-2004-12-4931 · Cited by 182
Characterization of the GAGE genes that are expressed in various human cancers and in normal testis.
Backer, O. D., Arden, K. C., Boretti, M., Vantomme, V., Smet, C. D., Czekay, S., Viars, C. S., Plaen, E. D., Brasseur, F., Chomez, P., et al. (1999) · PubMed · Cited by 167
Dissection of T-cell Antigen Specificity in Human Melanoma
Andersen, R. S., Thrue, C. A., Junker, N., Lyngaa, R., Donia, M., Ellebæk, E., Svane, I. M., Schumacher, T. N., thor Straten, P., & Hadrup, S. R. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2614 · Cited by 158
Mage-A Cancer/Testis Antigens Inhibit p53 Function by Blocking Its Interaction with Chromatin
Marcar, L., MacLaine, N. J., Hupp, T. R., & Meek, D. W. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1341 · Cited by 158
Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.
dos Santos, N. R., Torensma, R., de Vries, T. J., Schreurs, M. W. J., de Bruijn, D. R. H., Kater‐Baats, E., Ruiter, D. J., Adema, G. J., van Muijen, G. N. P., & van Kessel, A. G. (2000) · PubMed · Cited by 150
The Melanoma-Associated Antigen A3 Mediates Fibronectin-Controlled Cancer Progression and Metastasis
Liu, W., Cheng, S., Asa, S. L., & Ezzat, S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-2132 · Cited by 139
Identification of cancer/testis genes by database mining and mRNA expression analysis
Scanlan, M. J., Gordon, C., Williamson, B., Lee, S., Chen, Y., Stockert, E., Jungbluth, A. A., Ritter, G., Jäger, D., Jäger, E., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10276 · Cited by 138
miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma
Weeraratne, S. D., Amani, V. M., Neiss, A., Teider, N., Scott, D. K., Pomeroy, S. L., & Cho, Y. (2010) · Neuro-Oncology · doi:10.1093/neuonc/noq179 · Cited by 135
Melanoma-associated antigen genes – An update
Sang, M., Wang, L., Ding, C., et al. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.10.021 · Cited by 132
Ianzini, F., Kosmacek, E. A., Nelson, E. S., Napoli, E., Erenpreisa, J. A., Kalējs, M., & Mackey, M. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3364 · Cited by 125
Acevedo, H. F., Tong, J. Y., & Hartsock, R. J. (1995) · Cancer · Cited by 124
Identification of cancer/testis-antigen genes by massively parallel signature sequencing
Chen, Y., Scanlan, M. J., Venditti, C. A., Chua, R. A., Theiler, G., Stevenson, B. J., Iseli, C., Gure, A. O., Vasicek, T., Strausberg, R. L., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502583102 · Cited by 112
Kalējs, M., Ivanov, A., Gregory, P., Cragg, M. S., Emzinsh, D., Illidge, T., & Erenpreisa, J. A. (2006) · BMC Cancer · doi:10.1186/1471-2407-6-6 · Cited by 110
Ge, Y., Hong, X., Ju, S., & Zhang, X. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.03.010 · Cited by 96
Cancer-testis antigens MAGE-C1/CT7 and MAGE-A3 promote the survival of multiple myeloma cells
Atanackovic, D., Hildebrandt, Y., Jadczak, A., Cao, Y. W., Luetkens, T., Meyer, S., Kobold, S., Bartels, K., Pabst, C., Lajmi, N., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.014464 · Cited by 96
Nardiello, T. L., Jungbluth, A. A., Mei, A. H.-C., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1820 · Cited by 89
Rapid evolution of cancer/testis genes on the X chromosome
Stevenson, B. J., Iseli, C., Panji, S., Zahn‐Zabal, M., Hide, W., Old, L. J., Simpson, A. J., & Jongeneel, C. V. (2007) · BMC Genomics · doi:10.1186/1471-2164-8-129 · Cited by 86
Chen, Y. T., Venditti, C. A., Theiler, G., Stevenson, B. J., Iseli, C., Gure, A. O., Jongeneel, C. V., Old, L. J., & Simpson, A. J. G. (2005) · PubMed · Cited by 84
Dissecting the First Transcriptional Divergence During Human Embryonic Development
Baï, Q., Assou, S., Haouzi, D., Ramirez, J., Monzo, C., Becker, F., Gerbal‐Chaloin, S., Hamamah, S., & Vos, J. D. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-011-9301-3 · Cited by 82
Issa, J. J. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200311000-00007 · Cited by 80
MOS, aneuploidy and the ploidy cycle of cancer cells
Erenpreisa, J. A., & Cragg, M. S. (2010) · Oncogene · doi:10.1038/onc.2010.310 · Cited by 78
Zhu, X., Asa, S. L., & Ezzat, S. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-2003 · Cited by 77
Silva, W. A., Gnjatic, S., Ritter, E., Chua, R. A., Cohen, T., Hsu, M. L., Jungbluth, A. A., Altorki, N. K., Chen, Y., Old, L. J., et al. (2007) · PubMed · Cited by 75
Improving T-cell Therapy for Relapsed EBV-Negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4
Cruz, C. C., Gerdemann, U., Leen, A. M., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1873 · Cited by 74
Multiple Cancer Testis Antigens Function To Support Tumor Cell Mitotic Fidelity
Cappell, K. M., Sinnott, R., Taus, P., Maxfield, K., Scarbrough, M., & Whitehurst, A. W. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00686-12 · Cited by 73
Por, E. D., Byun, H.-J., Lee, E., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.084400 · Cited by 69
Saha, A., & Chatterjee, S. K. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02355.x · Cited by 68
Zeng, Y., He, Y., Yang, F., Mooney, S. M., Getzenberg, R. H., Orban, J. P., & Kulkarni, P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.210765 · Cited by 67
An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members
Gjerstorff, M. F., & Ditzel, H. J. (2008) · Tissue Antigens · doi:10.1111/j.1399-0039.2007.00997.x · Cited by 66
Self-citationExpression of cancer/testis antigens in prostate cancer is associated with disease progression
Suyama, T., Shiraishi, T., Zeng, Y., Yu, W., Parekh, N., Vessella, R. L., Luo, J., Getzenberg, R. H., & Kulkarni, P. (2010) · The Prostate · doi:10.1002/pros.21214 · Cited by 66
MageA2 restrains cellular senescence by targeting the function of PMLIV/p53 axis at the PML-NBs
Peche, L. Y., Scolz, M., Ladelfa, M. F., Monte, M., & Schneider, C. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.173 · Cited by 65
Yang, B., O’Herrin, S. M., Wu, J., Reagan‐Shaw, S., Ma, Y., Nihal, M., & Longley, B. J. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700548 · Cited by 60
Epigenetic Modulation of Solid Tumors as a Novel Approach for Cancer Immunotherapy
Sigalotti, L., Coral, S., Fratta, E., Lamaj, E., Danielli, R., Giacomo, A. M. D., Altomonte, M., & Maio, M. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.07.005 · Cited by 60
Bhatia, N., Xiao, T. Z., Rosenthal, K. A., Siddiqui, I. A., Thiyagarajan, S., Smart, B., Meng, Q., Zuleger, C., Mukhtar, H., Kenney, S. C., et al. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.355 · Cited by 59
Kim, Y., Park, H., Park, D., Lee, Y., Choe, J., Hahn, J.-H., Lee, H., Kim, Y.-M., & Jeoung, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095950 · Cited by 58
Gjerstorff, M. F., Harkness, L., Kassem, M. S., Frandsen, U., Nielsen, O., Lutterodt, M. C., Møllgård, K., & Ditzel, H. J. (2008) · Human Reproduction · doi:10.1093/humrep/den262 · Cited by 58
Self-citationMAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis
Yang, F., Zhou, X., Miao, X., Zhang, T., Hang, X., Tie, R., Liu, N., Tian, F., Wang, F., & Yuan, J. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-2915-9 · Cited by 57
Jäger, D., Unkelbach, M. H., Frei, C., et al. (2002) · PubMed · Cited by 55
Pedersen, A. E., Buus, S., & Claësson, M. H. (2005) · Cancer Letters · doi:10.1016/j.canlet.2005.04.012 · Cited by 53
Rapid αβ TCR-mediated responses in γδ T cells transduced with cancer-specific TCR genes
Hiasa, A., Nishikawa, H., Hirayama, M., Kitano, S., Okamoto, S., Chono, H., Yu, S. S., Mineno, J., Tanaka, Y., Minato, N., et al. (2009) · Gene Therapy · doi:10.1038/gt.2009.6 · Cited by 49
Yokoe, T., Tanaka, F., Mimori, K., Inoue, H., Ohmachi, T., Kusunoki, M., & Mori, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-0964 · Cited by 49
Daftarian, P. M., Song, G.-Y., Ali, S., Faynsod, M., Longmate, J., Diamond, D. J., & Ellenhorn, J. D. I. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0169 · Cited by 46
Wong, P.-P., Yeoh, C. C., Ahmad, A. S., Chelala, C., Gillett, C., Speirs, V., Jones, J. L., & Hurst, H. C. (2014) · Oncogene · doi:10.1038/onc.2014.45 · Cited by 44
D’Arcy, P., Maruwge, W., Wolahan, B., Ma, L., & Brodin, B. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095136 · Cited by 44
Toor, A. A., Payne, K. K., Chung, H. M., Sabo, R., Hazlett, A. F., Kmieciak, M., Sanford, K., Williams, D. C., Clark, W., Roberts, C. H., et al. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09225.x · Cited by 44
NY-ESO-1 expression and its serum immunoreactivity in esophageal cancer
Akçakanat, A., Kanda, T., Koyama, Y., Watanabe, M., Kimura, E., Yoshida, Y., Komukai, S., Nakagawa, S., Odani, S., Fujii, H., et al. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0768-3 · Cited by 43
Tumor-Infiltrating T Cells Correlate with NY-ESO-1-Specific Autoantibodies in Ovarian Cancer
Milne, K., Barnes, R. O., Girardin, A., Mawer, M. A., Nesslinger, N. J., Ng, A. V., Nielsen, J. S., Sahota, R. A., Tran, E., Webb, J. R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003409 · Cited by 43
Cancer/testis antigen expression and autologous humoral immunity to NY-ESO-1 in gastric cancer.
Wang, Y., Wu, X., Zhao, A., Yuan, Y., Chen, Y., Jungbluth, A. A., Gnjatic, S., Santiago, D., Ritter, G., Chen, W., et al. (2004) · PubMed · Cited by 41
Effects of Epithelial to Mesenchymal Transition on T Cell Targeting of Melanoma Cells
Woods, K., Pasam, A., Jayachandran, A., Andrews, M. C., & Cebon, J. S. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00367 · Cited by 38
Kim, Y., Park, D., Kim, H., Choi, M., Lee, H., Lee, Y. S., Choe, J., Kim, Y. M., & Jeoung, D. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.502047 · Cited by 37
Ectopic expression of cancer/testis antigen SSX2 induces DNA damage and promotes genomic instability
Greve, K. B. V., Lindgreen, J., Terp, M. G., Pedersen, C. B., Schmidt, S., Mollenhauer, J., Kristensen, S. B., Andersen, R. S., Relster, M. M., Ditzel, H. J., et al. (2014) · Molecular Oncology · doi:10.1016/j.molonc.2014.09.001 · Cited by 36
Self-citationYan, M., Himoudi, N., Basu, B. P., Wallace, R., Poon, E., Adams, S. P., Hasan, F., Xue, S., Wilson, N., Dalgleish, A. G., et al. (2011) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-011-1024-4 · Cited by 34
Cancer is a somatic cell pregnancy.
Old, L. J. (2007) · PubMed · Cited by 33
Kular, R. K., Yehiely, F., Kumar, K. U., Cilensek, Z. M., Bedi, R., & Deiss, L. P. (2009) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2008.0099 · Cited by 31
Qian, F., Gnjatic, S., Jäger, E., Santiago, D., Jungbluth, A. A., Grande, C., Schneider, S., Keitz, B. T., Driscoll, D., Ritter, G., et al. (2004) · PubMed · Cited by 29
Abate‐Daga, D., Speiser, D. E., Chinnasamy, N., Zheng, Z., Xu, H., Feldman, S. A., Rosenberg, S. A., & Morgan, R. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093321 · Cited by 27
Gjerstorff, M. F., Relster, M. M., Greve, K. B. V., Moeller, J. B., Eliáš, D., Lindgreen, J., Schmidt, S., Mollenhauer, J., Voldborg, B. G. R., Pedersen, C. B., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku852 · Cited by 25
Self-citationCancer–germline antigen vaccines and epigenetic enhancers: future strategies for cancer treatment
Gjerstorff, M. F., Burns, J. S., & Ditzel, H. J. (2010) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2010.485188 · Cited by 24
Self-citationEffects of CT-Xp Gene Knock down in Melanoma Cell Lines
Caballero, O. L., Cohen, T., Gurung, S., Chua, R. A., Lee, P., Chen, Y., Jat, P., & Simpson, A. J. G. (2013) · Oncotarget · doi:10.18632/oncotarget.921 · Cited by 24
Recent duplication and positive selection of the GAGE gene family
Liu, Y., Zhu, Q., & Zhu, N. (2007) · Genetica · doi:10.1007/s10709-007-9179-9 · Cited by 20
Evolutionary Origin and Human-Specific Expansion of a Cancer/Testis Antigen Gene Family
Zhang, Q., & Su, B. (2014) · Molecular Biology and Evolution · doi:10.1093/molbev/msu188 · Cited by 19
Smith, S. K., & Kipling, D. (2004) · Cytogenetic and Genome Research · doi:10.1159/000078219 · Cited by 17
Cited by
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
Havel, J. J., Chowell, D., & Chan, T. A. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0116-x · Cited by 2,286
Lung cancer immunotherapy: progress, pitfalls, and promises
Lahiri, A., Maji, A., Potdar, P. D., Singh, N., Parikh, P., Bisht, B., Mukherjee, A., & Paul, M. K. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01740-y · Cited by 1,102
Towards personalized, tumour-specific, therapeutic vaccines for cancer
Hu, Z., Ott, P. A., & Wu, C. J. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.131 · Cited by 1,067
Teaching an old dog new tricks: next-generation CAR T cells
Tokarew, N., Ogonek, J., Endres, S., von Bergwelt-Baildon, M., & Kobold, S. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0325-1 · Cited by 440
NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
Thomas, R., Al-Khadairi, G., Roelands, J., Hendrickx, W., Dermime, S., Bedognetti, D., & Decock, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00947 · Cited by 393
Metadata
- Authors
- Gjerstorff, M. F., Andersen, M. H., & Ditzel, H. J.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2015-06-30
- Volume
- 6
- Issue
- 18
- Pages
- 15772-15787
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1813394859
- Cited by
- 320
- References
- 98
- FWCI
- 13.60
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.